Results 261 to 270 of about 9,885,342 (364)

Formolized Herpes Virus Therapy and the Neutralizing Substance in Herpes Simplex11From the Dermatology Department, Vanderbilt Clinic (Professor J. Gardner Hopkins); the Bacteriology Department) College of Physicians and Surgeons, (Professor Frederick P. Gay), and the New York Post-Graduate Medical School and Hospital, Skin and Cancer Unit, (George M. MacKee, Director), of Columbia University.

, 1938
Samuel B. Frank
openalex   +1 more source

Imperial strategy of cancer cells through mitochondrial transfer

Molecular Oncology, EarlyView.
Cangkrama et al. demonstrated that cancer cells donate their mitochondria to fibroblasts through mitochondrial transfer, reprogramming them into ‘MitoCAF’. Likewise, our group has identified mitochondrial transfer from cancer cells to tumor infiltrating lymphocytes, resulting in mitochondrial ‘hijack’ and impaired antitumor immunity.
Takamasa Ishino, Yosuke Togashi
wiley   +1 more source

Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer. [PDF]

Breast Cancer
Nishina T, Tanioka M, Takada K, Tsukioki T, Takahashi Y, Shien T, Toyooka S.   +6 more
europepmc   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Impact of antithrombotic therapy on colonoscopy outcomes in FIT-positive patients: implications for polyp detection, diverticulosis and normal findings. [PDF]

BMJ Open Gastroenterol
Abu-Freha N, Tatour M, Baker FA, Saadi T, Hazzan R.   +4 more
europepmc   +1 more source

Advances in cancer therapy: clinical benefit of new cancer drugs

, 1899
Daniel Tobias Michaeli, Julia Caroline Michaeli, Thomas Michaeli   +2 more
openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Efficacy and safety of proton therapy and photon therapy for patients with craniopharyngioma: a systematic review and meta‑analysis. [PDF]

Pituitary
Pan LS, Zhang J, Xiong YT, Zhan JB, Wang QY, Hong T.   +5 more
europepmc   +1 more source

The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies

Molecular Oncology, EarlyView.
RAS‐targeted therapies have become a clinical reality. Although promising results in patients have been achieved, there are still challenges ahead such as coping with drug resistance. Here we summarize selected RAS inhibitors targeting either individual KRAS mutant isoforms (KRASG12C, KRASG12D, KRASG12V) or exhibiting a wider inhibitory spectrum ...
Matthias Drosten, Mariano Barbacid
wiley   +1 more source

Investigating a Telerehabilitation Platform Integrated With a Rehabilitation Robot Using Microsoft HoloLens 2 for Upper-Limb Therapy: Pilot Usability Study. [PDF]

JMIR Rehabil Assist Technol
Khan MMR, Zarif MII, Pillai A, Wang I, Rahman MH.   +4 more
europepmc   +1 more source